Former Chief Scientific Officer, Head of Research and Development · GILEAD SCIENCES, INC. (GILD)

John McHutchison

A named executive officer of GILEAD SCIENCES in every fiscal year CompBrief holds from FY2018 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$5,435,962

Salary $640,096Stock awards $2,683,888

FY2018: $7,274,972

7th of 9 named executive officers at Gilead Sciences by FY2019 total.

9 named officers on file for GILEAD SCIENCES, FY2019

John McHutchison’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 11 equity grants, each cited to its filing
  • GILD’s disclosed peer group of 10 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how GILEAD SCIENCES’s whole pay program stands against its peers

  • GILEAD SCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GILD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 24, 2020 (DEF 14A).

Free

Get John McHutchison’s full pay file as a PDF — free

More than this page: up to 10 years of John’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

John McHutchison compensation by year

GILEAD SCIENCES Summary Compensation Table · all 2 fiscal years held
In US dollars, as GILEAD SCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019
Salary$940,038$640,096
Bonus$0$0
Stock awards$2,528,070$2,683,888
Option awards$2,500,114$999,978
Non-equity incentive$1,296,750$0
Pension and deferred compensation$0$0
All other$10,000$1,112,000
Total$7,274,972$5,435,962

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GILEAD SCIENCES, INC. DEF 14A filed March 24, 2020, accession 0001206774-20-000886, and prior-year filings. Open the filing on EDGAR.

How this page was built: the GILEAD SCIENCES, INC. filed document, accession 0001206774-20-000886. Every figure is read from that document and cited to the page and table it appears in. Filed March 24, 2020.

$7.3M
$5.4M
FY18
FY19
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
PSU5,610$364,538—
RSU4,473$290,656—
RSU4,080$265,118—
RSU3,359$218,268—
RSU3,165$205,662—
RSU1,920$124,762—
RSU240$15,595—

Per the Outstanding Equity Awards at Fiscal Year-End table in GILEAD SCIENCES, INC.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

GILEAD SCIENCES’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Daniel O'DayChairman and Chief Executive Officer$29,107,854
Johanna MercierChief Commercial Officer$8,049,386
Gregg AltonFormer Interim Chief Executive Officer and Chief$7,843,788
Laura HamillFormer Executive Vice President Worldwide Commercial Operations$7,672,442
Robin WashingtonFormer Executive Vice President, Chief Financial Officer$6,341,005
Andrew DickinsonExecutive Vice President, Chief Financial Officer$5,609,471
John McHutchison · this pageFormer Chief Scientific Officer, Head of Research and Development$5,435,962
Brett PletcherExecutive Vice President, Corporate Affairs and General Counsel$5,032,680
Merdad ParseyChief Medical Officer$3,119,553

The full GILEAD SCIENCES compensation record

free company brief

This page is one person within GILEAD SCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the GILEAD SCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GILEAD SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

John McHutchison's compensation dossier · One-time report. No refunds.